You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Details for Patent: 7,559,325


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,559,325
Title:Aerosolization apparatus with air inlet shield
Abstract: An aerosolization apparatus comprises a housing defining a chamber having a plurality of air inlets. The chamber contains an aersolizable pharmaceutical formulation or is sized to receive a receptacle which contains an aerosolizable pharmaceutical formulation. A shield covers at least one of the air inlets or a portion of at least one of the air inlets. The shield prevents blockage of the air inlet by a user grasping the apparatus and inadvertently covering the air inlet. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the receptacle.
Inventor(s): Dunkley; Michael John (Nottingham, GB), Tuckwell; Jon David (Cambridgeshire, GB), Vernon Harcourt; Edward William (Cambridge, GB), Shirgoankar; Sameer (London, GB)
Assignee: Novartis Pharma AG (Basel, CH)
Application Number:10/822,850
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,559,325: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 7,559,325, providing a detailed analysis of its scope, claims, and the broader patent landscape it inhabits.

Overview of the Patent

United States Patent 7,559,325, titled "Capsule, Filled with a Medicine, in Particular an Inhalable Medicine," was granted on July 14, 2009. The patent is assigned to Pharmachemie B.V., a company based in Haarlem, Netherlands, and lists Dunkley et al. as the inventors[5].

Field of the Invention

The patent pertains to an assembly of a tube-shaped body and a tube-shaped cap, designed to form a capsule for enclosing medicine, particularly inhalable medicine. This invention is significant in the pharmaceutical industry, especially in the development of inhalable drug delivery systems[5].

Claims of the Patent

The patent includes 14 claims that define the scope of the invention. Here is a breakdown of the types of claims typically found in such patents:

Independent Claims

Independent claims are the broadest and most comprehensive claims in a patent. For example, Claim 1 might describe the overall assembly of the tube-shaped body and cap, including the snap connection that joins them.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding specific details or limitations. For instance, Claim 2 might specify the material used for the tube-shaped body or the design of the snap connection.

Method Claims

If applicable, method claims would describe the process of manufacturing or using the capsule. These claims are important for protecting the invention's functionality.

Scope of the Invention

The scope of the invention is defined by the claims and the description provided in the patent specification. Here are some key aspects:

Structural Elements

  • The patent describes a tube-shaped body and a tube-shaped cap, both open at one distal side, which are connected by a snap connection[5].

Functional Aspects

  • The assembly is designed to enclose medicine, with a particular focus on inhalable medicines. This indicates the invention's utility in delivering drugs through inhalation.

Novelty and Nonobviousness

To be patentable, the invention must be novel and nonobvious. The patent examiner would have evaluated whether this assembly was not fully anticipated by prior art and whether it would not have been readily within the ordinary skills of a competent artisan at the time of the invention[4].

Patent Landscape

Understanding the patent landscape involves analyzing related patents, competitors, and potential gaps or opportunities.

Related Patents

The patent references several prior patents, such as U.S. Patent 3,991,761 A, U.S. Patent 4,338,931 A, and U.S. Patent 6,488,027 B1, which are cited in the "References Cited" section. These patents likely relate to similar drug delivery systems or capsule designs[5].

Competitors

Companies in the pharmaceutical and medical device sectors that develop inhalable drug delivery systems would be potential competitors. Analyzing their patents and products can help identify market gaps and opportunities.

Patent Analytics

Using patent analytics tools, such as those described by Schwegman, can help in categorizing patents by claims and scope concepts. This can provide a clear picture of which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Claim Coverage Matrix

A Claim Coverage Matrix can be used to visualize which patents and claims are protecting the technology intended by the invention. This matrix helps in identifying whether the claims cover the desired scope and where there might be gaps in coverage. For example, if the matrix shows that certain scope concepts related to inhalable medicine delivery are not well-covered, it could indicate an area for future innovation or patent filings[3].

Practical Applications and Future Directions

The invention described in U.S. Patent 7,559,325 has practical applications in the pharmaceutical industry, particularly in the development of inhalable medicines. Here are some potential future directions:

New Design Options

Using claim charts and scope concepts, engineers, scientists, and management can determine new design options that expand the coverage of the current patent or fill gaps in the existing technology[3].

Market Opportunities

Identifying gaps in the patent landscape can reveal market opportunities. For instance, if there is a lack of patents covering specific types of inhalable medicines, this could be an area for innovation and potential market dominance.

Legal Rights and Protection

A valid patent grants the holder the exclusive right to make, use, import, sell, or offer for sale the covered invention in the United States for a period of 20 years from the date the patent application was filed. This right to exclude others is a powerful tool for protecting intellectual property and maintaining market exclusivity[4].

Conclusion

Understanding the scope and claims of U.S. Patent 7,559,325 is essential for anyone involved in the development or use of inhalable medicine delivery systems. By analyzing the patent's claims, the broader patent landscape, and using tools like patent analytics, businesses can identify opportunities for innovation and protect their intellectual property effectively.

Key Takeaways

  • Patent Scope: The patent covers an assembly of a tube-shaped body and cap for enclosing inhalable medicine.
  • Claims: The patent includes 14 claims defining the invention's scope, including structural and functional aspects.
  • Patent Landscape: Analyzing related patents and competitors helps in identifying market gaps and opportunities.
  • Patent Analytics: Tools like Claim Coverage Matrix and scope concepts are crucial for understanding and managing patent portfolios.
  • Legal Rights: A valid patent grants exclusive rights to the holder for 20 years from the application date.

FAQs

What is the main invention described in U.S. Patent 7,559,325?

The main invention is an assembly of a tube-shaped body and a tube-shaped cap designed to form a capsule for enclosing medicine, particularly inhalable medicine.

How many claims are included in U.S. Patent 7,559,325?

The patent includes 14 claims.

What is the significance of the snap connection in the patent?

The snap connection is a key feature that joins the tube-shaped body and cap, forming the capsule.

How can patent analytics help in managing intellectual property related to this patent?

Patent analytics tools help in categorizing patents by claims and scope concepts, identifying gaps or opportunities in the patent landscape, and determining the value of patent claims.

What are the legal rights granted by U.S. Patent 7,559,325?

The patent grants the holder the exclusive right to make, use, import, sell, or offer for sale the covered invention in the United States for 20 years from the date the patent application was filed.

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess ...
  2. USAGov: U.S. Patent and Trademark Office (USPTO)
  3. SLWIP: Patent Analytics | Intellectual Property Law
  4. CRS Reports: Patents and Innovation Policy
  5. US Patent Document: Capsule, Filled with a Medicine, in Particular an Inhalable Medicine

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,559,325

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Mylan Speciality Lp TOBI PODHALER tobramycin POWDER;INHALATION 201688-001 Mar 22, 2013 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 7,559,325

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2004229446 ⤷  Try for Free
Austria 549051 ⤷  Try for Free
Canada 2520032 ⤷  Try for Free
Cyprus 1113859 ⤷  Try for Free
Denmark 1610850 ⤷  Try for Free
European Patent Office 1610850 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.